| Serial Number | 87235356 |
| Word Mark | AURX |
| Filing Date | Monday, November 14, 2016 |
| Status | 701 - SECTION 8 - ACCEPTED |
| Status Date | Thursday, December 19, 2024 |
| Registration Number | 5413895 |
| Registration Date | Tuesday, February 27, 2018 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 15, 2017 |
| Goods and Services | Dietary supplements; nutritional supplements; medical foods, namely, medical food supplements and dietetic food supplements, both containing short-chain fatty acids in single molecule form with a release agent that enhances solubility and absorption; nutritional ingredients, namely, a blend of nutrients, namely, short-chain fatty acids in single molecule form with a release agent that ensures solubility and absorption, that are an integral component of medicals foods, for short-chain fatty acid deficiencies in individuals with Autism Spectrum Disorder; nutraceuticals for use as dietary supplements and nutritional supplements; vitamin preparations and mineral preparations to mitigate short-chain fatty acid microbiome deficiencies in individuals with Autism Spectrum Disorder; dietary supplements for restoring health in individuals with diseases, disorders, nutritional deficiencies, and adverse health conditions; therapeutic agents for human medical, medicinal, and therapeutic purposes, namely, increasing butyric acid and acetic acid in the gastrointestinal tract; functional nutrients containing butyric acid and acetic acid to mitigate short-chain fatty acid gut microbiome deficiencies in individuals with Autism Spectrum Disorder; pharmaceutical preparations to mitigate short-chain fatty acid gut microbiome deficiencies in individuals with Autism Spectrum Disorder; specialty nutraceuticals for the dietary management of diseases, disorders, and nutritional deficiencies, namely, short-chain fatty acid gut microbiome deficiencies in individuals with Autism Spectrum Disorder and deficiencies of butyrate in the gastrointestinal tract |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, November 18, 2016 |
| Primary Code | 005 |
| First Use Anywhere Date | Monday, July 17, 2017 |
| First Use In Commerce Date | Monday, July 17, 2017 |
| Party Name | Tesseract Medical Research, LLC |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Napa, CA 94558 |
| Party Name | Tesseract Medical Research, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Napa, CA 94558 |
| Party Name | Tesseract Medical Research, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Napa, CA 94558 |
| Event Date | Event Description |
| Tuesday, February 21, 2017 | ASSIGNED TO EXAMINER |
| Tuesday, February 21, 2017 | NON-FINAL ACTION WRITTEN |
| Thursday, November 17, 2016 | NEW APPLICATION ENTERED |
| Friday, November 18, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, February 21, 2017 | NON-FINAL ACTION E-MAILED |
| Tuesday, February 21, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Saturday, May 6, 2017 | NON-FINAL ACTION E-MAILED |
| Saturday, May 6, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, June 26, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, March 30, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, April 13, 2017 | ASSIGNED TO LIE |
| Thursday, April 20, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, April 20, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, May 6, 2017 | NON-FINAL ACTION WRITTEN |
| Monday, June 26, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, July 11, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, August 15, 2017 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 15, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 10, 2017 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, December 27, 2017 | TEAS STATEMENT OF USE RECEIVED |
| Wednesday, December 27, 2017 | USE AMENDMENT FILED |
| Friday, January 12, 2018 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Saturday, January 13, 2018 | STATEMENT OF USE PROCESSING COMPLETE |
| Tuesday, February 27, 2018 | REGISTERED-PRINCIPAL REGISTER |
| Monday, February 27, 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Tuesday, April 2, 2024 | TEAS SECTION 8 RECEIVED |
| Tuesday, June 27, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, July 11, 2017 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, July 11, 2017 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, July 11, 2017 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, July 11, 2017 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, July 26, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, January 19, 2018 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Saturday, January 20, 2018 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Wednesday, December 18, 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Thursday, December 19, 2024 | REGISTERED - SEC. 8 (6-YR) ACCEPTED |
| Thursday, December 19, 2024 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED |